Cite
HARVARD Citation
Lo Nigro, L. et al. (2019). "Feasible and effective administration of Bortezomib with Rituximab in children with relapsed/resistant B-cell precursor acute lymphoblastic leukemia (BCP-ALL): A step toward the first line". Pediatric hematology and oncology. pp. 438-444. [Online].